Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
deCODE genetics logo — company profile

deCODE genetics

Founded 1996 Iceland Iceland 194 employees Seed Biotechnology, Health Care

General Information

Company Name deCODE genetics
Founded Year 1996
Location Iceland Iceland
Founders / Decision Makers
Team member
Employees 194
Industries Biotechnology, Health Care
Funding Stage Seed
Social

Get notified when deCODE genetics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About deCODE genetics

deCODE genetics is a global leader in analyzing and understanding the human genome. Founded in 1996 and headquartered in Iceland, the company has made significant strides in identifying genetic risk factors for numerous common diseases. Through its unique expertise and population resources, deCODE has been able to make groundbreaking discoveries in the field of biotechnology and healthcare. Its ultimate goal is to leverage this genetic information to develop innovative methods for diagnosing, treating, and preventing diseases.

The company's last investment was a Seed Round investment on 01 January 1998, with Atlas Venture as the investor. This investment has provided deCODE genetics with the necessary support to continue its pioneering work in decoding the intricacies of the human genome and furthering its research in disease prevention and treatment.

Services & Products

Human gene discovery
genomic analysis
population genetics research
disease risk factor identification

Target Customers

Research institutions pharmaceutical companies healthcare organizations geneticists medical researchers

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
01 Jan 1998

deCODE genetics Alternatives & Competitors

deCODE genetics vs
Repertoire Immune Medicines
Repertoire Immune Medicines United States

Repertoire is a biotechnology company creating a new category of immune medicines for cancer and aut...

Series B
86 employees
Biotechnology, Health and Wellness
deCODE genetics vs
Biogenet
Biogenet

Your trusted partner in uncovering the genetic blueprint of health and disease.

Biotechnology
deCODE genetics vs
converger.ai
converger.ai South Africa

converger.ai - intelligent data analytics to improve health

1 employees

FAQ About deCODE genetics

deCODE genetics is a global leader in analysing and understanding the human genome. Using its unique expertise and population resources, deCODE has discovered genetic risk factors for dozens of common diseases. The purpose of understanding the genetics of disease is to use that information to create...
deCODE genetics was founded in 1996.
deCODE genetics is headquartered in Iceland.
deCODE genetics operates in the following industries: Biotechnology, Health Care.
deCODE genetics has approximately 194 employees.
deCODE genetics has completed 1 funding round. The latest funding stage is Seed.
deCODE genetics offers: Human gene discovery, genomic analysis, population genetics research, disease risk factor identification.
Top alternatives and competitors to deCODE genetics include Repertoire Immune Medicines, Biogenet, converger.ai, Phenometrix, Ambry Genetics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
deCODE genetics and Repertoire Immune Medicines are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors deCODE genetics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes